FdaApplication
ANDA 076264
Identifiers
- fda_app_no: ANDA076264
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | ANDA |
| approval_date | 2002-03-22 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 100MG | TABLET;ORAL |
| NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 25MG | TABLET;ORAL |
| NALTREXONE HYDROCHLORIDE | NALTREXONE HYDROCHLORIDE | 50MG | TABLET;ORAL |
3 products